Literature DB >> 19350202

Prostacyclin treatment normalises the MCA flow velocity in nimodipine-resistant cerebral vasospasm after aneurysmal subarachnoid haemorrhage: a pilot study.

Lars-Owe D Koskinen1, Magnus Olivecrona, Marie Rodling-Wahlström, Silvana Naredi.   

Abstract

BACKGROUND: Cerebral vasospasm triggered by subarachnoid haemorrhage is one of the major causes of post-haemorrhage morbidity and mortality. Several treatment modalities have been proposed, and none of them are fully effective.
METHODS: In this study we treated five patients with prostacyclin suffering vasospasm after a ruptured aneurysm not responding to high i.v. doses of nimodipine. All patients were severely ill, unconscious and in need of intensive care.
FINDINGS: A low dose of prostacyclin i.v. infusion for 72 h reversed the vasospasm as measured by transcranial Doppler technique. The mean MCA blood flow velocity decreased from 199 +/- 31 cm/s to 92 +/- 6 cm/s within 72 h after the start of the prostacyclin infusion.
CONCLUSIONS: We suggest that low-dose prostacyclin treatment, an old treatment strategy, can be a treatment option in patients with vasospasm not responding to ordinary measures.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19350202     DOI: 10.1007/s00701-009-0295-4

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  4 in total

1.  Prostacyclin infusion may prevent secondary damage in pericontusional brain tissue.

Authors:  Peter Reinstrup; Carl-Henrik Nordström
Journal:  Neurocrit Care       Date:  2011-06       Impact factor: 3.210

2.  Prostacyclin influences the pressure reactivity in patients with severe traumatic brain injury treated with an ICP-targeted therapy.

Authors:  Lars-Owe D Koskinen; Anders Eklund; Nina Sundström; Magnus Olivecrona
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

3.  The effects of continuous prostacyclin infusion on regional blood flow and cerebral vasospasm following subarachnoid haemorrhage: study protocol for a randomised controlled trial.

Authors:  Rune Rasmussen; Jørn Wetterslev; Trine Stavngaard; Jane Skjøth-Rasmussen; Per Olof Grände; Niels Vidiendal Olsen; Bertil Romner
Journal:  Trials       Date:  2012-07-02       Impact factor: 2.279

4.  The Updated Role of the Blood Brain Barrier in Subarachnoid Hemorrhage: From Basic and Clinical Studies.

Authors:  Sheng Chen; PengLei Xu; YuanJian Fang; Cameron Lenahan
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.